Comparison of serum PCSK9 between HCV patients and non-infected patients without any severe liver diseases showed that PCSK9 levels were 170 (40–360) ng/mL in the non-infected controls and 218 (99–418) ng/mL in HCV patients and were significantly higher in the HCV group (Figure 1A). The gene discussed is PCSK9; the disease is liver disorder.